← Leaderboards
Christian Brander
Massachusetts General Hospital
$5,020,952
Attributed
$5,020,952
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,020,952 · 5
By mechanism
R01$2,821,586 · 2
P01$1,719,965 · 2
R56$479,401 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Sylvie Le Gall$9,769,555
- Georg Michael Lauer$24,583,765
- Marcus Altfeld$19,256,149
- Sara Isabel Pai$12,404,338
- Todd M Allen$28,600,717
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralHiv InfectionsBaseCellsImmuneImmunityLinkVirusT-LymphocyteCohortResponsePatternInfectionSamplingAffectEpitopesAntigensHiv VaccineMediatingIn VivoKineticsT Cell ResponseCd4 Positive T LymphocytesReporting
Grant awards (17)
Fusion peptide specific B cell responses and the role of follicular T cells in accelerated antibody maturation$386,487
P01 · FY2025 · AI · contact PI
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics$244,075
P01 · FY2021 · AI · contact PI
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics$299,115
P01 · FY2020 · AI · contact PI
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics$290,755
P01 · FY2019 · AI · contact PI
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics$273,252
P01 · FY2018 · AI · contact PI
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics$226,281
P01 · FY2017 · AI · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$213,760
R01 · FY2011 · DE · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$220,371
R01 · FY2010 · DE · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$153,580
R01 · FY2009 · DE · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$122,994
R01 · FY2009 · DE · contact PI
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes$406,947
R01 · FY2008 · AI · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$276,574
R01 · FY2008 · DE · contact PI
Breadth and Functional Assessment of "Toggle"-Peptide-specific T Cell Responses$479,401
R56 · FY2007 · AI · contact PI
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes$329,866
R01 · FY2007 · AI · contact PI
Consequences of acute HIV infection on the EBV-specific immunity$298,400
R01 · FY2007 · DE · contact PI
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes$427,219
R01 · FY2006 · AI · contact PI
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes$371,875
R01 · FY2005 · AI